These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31680940)

  • 21. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin as a single injection for Pasteurellaceae respiratory infections in cattle using population pharmacokinetics and Monte Carlo simulations.
    Paulin A; Schneider M; Dron F; Woehrle F
    J Vet Pharmacol Ther; 2018 Feb; 41(1):39-50. PubMed ID: 28542866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations on macrolide resistance and susceptibility testing performance in field isolates collected from clinical bovine respiratory disease cases.
    DeDonder KD; Harhay DM; Apley MD; Lubbers BV; Clawson ML; Schuller G; Harhay GP; White BJ; Larson RL; Capik SF; Riviere JE; Kalbfleisch T; Tessman RK
    Vet Microbiol; 2016 Aug; 192():186-193. PubMed ID: 27527782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
    Balaje RM; Sidhu PK; Kaur G; Rampal S
    Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the diagnostic performance of bacterial culture of nasopharyngeal swab and bronchoalveolar lavage fluid samples obtained from calves with bovine respiratory disease.
    Capik SF; White BJ; Lubbers BV; Apley MD; DeDonder KD; Larson RL; Harhay GP; Chitko-McKown CG; Harhay DM; Kalbfleisch TS; Schuller G; Clawson ML
    Am J Vet Res; 2017 Mar; 78(3):350-358. PubMed ID: 28240958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
    Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
    J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
    Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
    Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
    Cao C; Qu Y; Sun M; Qiu Z; Huang X; Huai B; Lu Y; Zeng Z
    Front Microbiol; 2015; 6():759. PubMed ID: 26257726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and
    Pelligand L; Lees P; Sidhu PK; Toutain PL
    Front Microbiol; 2019; 10():1237. PubMed ID: 31244793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats.
    Fernández-Varón E; Cárceles-García C; Serrano-Rodríguez JM; Cárceles-Rodríguez CM
    BMC Vet Res; 2016 Oct; 12(1):232. PubMed ID: 27737655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics of florfenicol for calf pneumonia pathogens.
    Illambas J; Potter T; Sidhu P; Rycroft AN; Cheng Z; Lees P
    Vet Rec; 2013 Mar; 172(13):340. PubMed ID: 23482237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Guo LL; Gao RY; Wang LH; Lin SJ; Fang BH; Zhao YD
    Front Vet Sci; 2021; 8():715887. PubMed ID: 34869712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
    Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
    PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.